tiprankstipranks
Trending News
More News >
Sumitomo Chemical Co Ltd (JP:4005)
:4005
Advertisement

Sumitomo Chemical Co (4005) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4005

Sumitomo Chemical Co

(4005)

Select Model
Select Model
Select Model
Neutral 60 (OpenAI - 4o)
Rating:60Neutral
Price Target:
¥451.00
▼(-1.40% Downside)
Sumitomo Chemical Co's overall stock score is driven by its financial resilience and attractive valuation, despite technical weakness and mixed earnings call results. The company's ability to manage leverage and improve profitability will be key to future performance.

Sumitomo Chemical Co (4005) vs. iShares MSCI Japan ETF (EWJ)

Sumitomo Chemical Co Business Overview & Revenue Model

Company DescriptionSumitomo Chemical Co., Ltd. is a leading chemical manufacturer based in Japan, operating in various sectors including petrochemicals, agricultural chemicals, and specialty chemicals. The company focuses on producing a wide range of products such as plastics, fertilizers, pharmaceuticals, and electronic materials. With a commitment to innovation and sustainability, Sumitomo Chemical serves diverse industries including automotive, electronics, agriculture, and healthcare.
How the Company Makes MoneySumitomo Chemical generates revenue through multiple key streams, primarily from the sale of its chemical products across different sectors. The company’s petrochemical division produces basic chemicals and plastics that are utilized in a wide range of applications, while its agricultural chemicals segment offers pesticides and fertilizers that support global food production. Additionally, the specialty chemicals division contributes to revenue through high-value products used in electronics and pharmaceuticals. Strategic partnerships with other companies, including joint ventures and collaborations for research and development, enhance its product offerings and market reach. Factors such as global demand for chemicals, innovations in sustainable practices, and expansion into emerging markets also play significant roles in bolstering its earnings.

Sumitomo Chemical Co Earnings Call Summary

Earnings Call Date:Nov 04, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Jan 30, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed outlook. While there were significant improvements in core operating income and Sumitomo Pharma's performance, the overall sales revenue declined, and nonrecurring losses impacted the financials. The sentiment is balanced by positive strides in financial position and certain segments.
Q2-2025 Updates
Positive Updates
Significant Improvement in Core Operating Income
Core operating income increased by JPY 79.2 billion year-over-year to JPY 108.7 billion, driven by strong sales at Sumitomo Pharma and favorable foreign exchange and tax adjustments.
Sumitomo Pharma Performance
Sumitomo Pharma's core operating income increased by JPY 94.3 billion year-over-year, attributed to expanded sales of ORGOVYX and GEMTESA, as well as gains from partial divestiture of the Asian business.
Essential & Green Materials Segment Improvement
Despite a loss, the Essential & Green Materials segment saw an improvement of JPY 16.1 billion year-over-year due to better profit margins from synthetic resins and aluminum.
Financial Position Strengthening
Interest-bearing liabilities decreased by JPY 94.5 billion, and equity increased by JPY 105.2 billion compared to the previous term's end.
Negative Updates
Decline in Overall Sales Revenue
Total sales revenue decreased by JPY 146 billion year-on-year, with declines in all segments except Sumitomo Pharma.
Nonrecurring Items Loss
Nonrecurring items led to a total loss of JPY 5 billion, a deterioration compared to a profit of JPY 91.8 billion in the previous year.
ICT & Mobility Solutions Segment Decline
Core operating income in the ICT & Mobility Solutions segment decreased by JPY 10.5 billion year-over-year, impacted by lower selling prices and shipments due to yen appreciation.
Free Cash Flow Deterioration
Free cash flow stood at JPY 41 billion, a deterioration by JPY 97 billion compared to the previous year.
Company Guidance
During the fiscal year 2025 second quarter conference call, Sumitomo Chemical's core operating income increased significantly by JPY 79.2 billion year-over-year, reaching JPY 108.7 billion, while net income attributable to owners of the parent rose by JPY 46.2 billion to JPY 39.7 billion. Sales revenue, however, decreased by JPY 146 billion to JPY 1,954 billion. The company benefited from strong sales at Sumitomo Pharma, foreign exchange gains due to a weaker yen, and a reduction in corporate income tax expenses. Despite a loss of JPY 5 billion in nonrecurring items this quarter, the company recorded an operating income of JPY 103.7 billion. The average exchange rate was JPY 146.02 to $1, and the naphtha price was JPY 64,900 per kiloliter. For the full fiscal year, Sumitomo Chemical revised its core operating profit forecast to JPY 185 billion, anticipating a JPY 35 billion increase compared to the previous forecast, attributed to improved performance trends and partial sales of Petro Rabigh shares.

Sumitomo Chemical Co Financial Statement Overview

Summary
Sumitomo Chemical Co shows resilience with healthy profit margins and strong cash flow generation. However, challenges such as declining revenue growth, high leverage, and low return on equity are concerns.
Income Statement
65
Positive
Sumitomo Chemical Co's income statement shows a mixed performance. The TTM data indicates a slight decline in revenue growth at -3.3%, but the company maintains a healthy gross profit margin of 27.8%. The net profit margin is relatively low at 1.5%, indicating challenges in converting revenue into profit. The EBIT and EBITDA margins are moderate at 7.5% and 12.5%, respectively, suggesting operational efficiency but room for improvement in profitability.
Balance Sheet
60
Neutral
The balance sheet reveals a high debt-to-equity ratio of 1.43, indicating significant leverage, which could pose financial risks. However, the equity ratio stands at 26.6%, showing a reasonable level of equity financing. The return on equity is low at 1.1%, reflecting challenges in generating returns for shareholders.
Cash Flow
70
Positive
Cash flow analysis shows positive trends, with a strong free cash flow growth rate of 33.6% in the TTM period. The operating cash flow to net income ratio is 0.22, indicating adequate cash generation relative to net income. The free cash flow to net income ratio is 0.44, suggesting a solid conversion of earnings into free cash flow.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.52T2.61T2.45T2.90T2.77T2.29T
Gross Profit717.34B725.48B499.69B820.93B873.86B771.20B
EBITDA289.46B321.64B-258.31B199.08B388.68B306.28B
Net Income9.69B38.59B-311.84B6.99B162.13B46.04B
Balance Sheet
Total Assets3.33T3.44T3.93T4.17T4.31T3.99T
Cash, Cash Equivalents and Short-Term Investments202.65B209.84B217.45B305.84B389.42B360.92B
Total Debt1.25T1.29T1.56T1.46T1.35T1.35T
Total Liabilities2.27T2.37T2.77T2.68T2.61T2.51T
Stockholders Equity885.87B900.79B965.75B1.17T1.22T1.02T
Cash Flow
Free Cash Flow137.03B102.56B-204.19B-31.96B64.25B253.65B
Operating Cash Flow269.28B233.03B-51.32B111.62B171.72B374.46B
Investing Cash Flow-48.54B79.90B-112.24B-19.41B-115.42B-177.39B
Financing Cash Flow-281.65B-295.45B49.25B-178.50B-81.39B-39.97B

Sumitomo Chemical Co Technical Analysis

Technical Analysis Sentiment
Positive
Last Price457.40
Price Trends
50DMA
463.05
Negative
100DMA
422.59
Positive
200DMA
379.57
Positive
Market Momentum
MACD
-0.43
Negative
RSI
51.66
Neutral
STOCH
84.63
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4005, the sentiment is Positive. The current price of 457.4 is above the 20-day moving average (MA) of 454.20, below the 50-day MA of 463.05, and above the 200-day MA of 379.57, indicating a neutral trend. The MACD of -0.43 indicates Negative momentum. The RSI at 51.66 is Neutral, neither overbought nor oversold. The STOCH value of 84.63 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4005.

Sumitomo Chemical Co Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥1.64T13.747.48%3.15%3.55%95.65%
72
Outperform
¥687.97B15.2719.69%3.41%10.06%18.03%
69
Neutral
$9.17T17.9810.87%2.16%3.77%0.35%
62
Neutral
¥495.03B60.981.08%3.53%-1.94%-84.08%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
$703.12B8.298.79%2.64%-1.64%
54
Neutral
$1.10T10.091.09%3.97%-11.50%25.86%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4005
Sumitomo Chemical Co
469.20
102.65
28.00%
JP:3407
Asahi Kasei
1,299.50
259.24
24.92%
JP:3405
Kuraray Co
1,516.50
-396.72
-20.74%
JP:4188
Mitsubishi Chemical Holdings
837.70
38.96
4.88%
JP:4021
Nissan Chemical
5,106.00
-94.96
-1.83%
JP:4063
Shin-Etsu Chemical Co
4,434.00
-1,035.36
-18.93%

Sumitomo Chemical Co Corporate Events

Sumitomo Chemical Reports Mixed Q2 2025 Results
Nov 5, 2025

Sumitomo Chemical Co., Ltd. is a diversified chemical company based in Japan, operating in sectors such as agrochemicals, pharmaceuticals, and petrochemicals, with a focus on innovative solutions and sustainable practices.

Sumitomo Chemical Reports Q2 Financial Impacts
Nov 4, 2025

Sumitomo Chemical Co., Ltd. reported a share of loss of ¥17,513 million due to the poor financial performance of Rabigh Refining and Petrochemical Company, an equity-method affiliate. Additionally, the company recorded a foreign exchange gain of ¥15,232 million, attributed to fluctuations in foreign exchange rates impacting assets and liabilities in foreign currencies.

The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.

Sumitomo Chemical Revises Financial Forecasts Amid Strong North American Sales
Nov 4, 2025

Sumitomo Chemical announced variances between its forecasted and actual financial results for the second quarter ending March 31, 2026, with stronger than expected sales of ORGOVYX in North America and reduced expenses leading to higher core operating and net income. Additionally, the company revised its full-year forecast, anticipating continued strong performance in North America and incorporating impacts from the partial sale of shares in Petro Rabigh, which is expected to positively affect its financial outcomes.

The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.

Sumitomo Chemical Reports Q2 FY2025 Financial Results
Nov 4, 2025

Sumitomo Chemical Co. reported its consolidated financial results for the second quarter of fiscal year 2025, showing a decline in sales revenue by 11.8% compared to the previous year. Despite this, the company experienced a significant increase in core operating income by 268.8%, indicating improved recurring earnings capacity. The financial results reflect a challenging market environment but also highlight the company’s ability to enhance operational efficiency. The exclusion of XUYOU Electronic Materials (Wuxi) Co., Ltd. from consolidation and a revision of financial forecasts for the fiscal year were noted, impacting stakeholders’ expectations.

The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.

Sumitomo Chemical to Acquire Tanaka Chemical as Wholly-Owned Subsidiary
Oct 28, 2025

Sumitomo Chemical Co., Ltd. is set to make Tanaka Chemical Corporation a wholly-owned subsidiary through a simplified share exchange, effective January 30, 2026. This strategic move aims to strengthen Sumitomo’s position in the rechargeable battery market by leveraging Tanaka’s expertise in cathode materials, aligning with Sumitomo’s growth strategy and enhancing its technological capabilities in response to increasing demand for energy-efficient solutions.

The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.

Sumitomo Chemical Reduces Stake in Petro Rabigh, Strengthening Financial Strategy
Oct 22, 2025

Sumitomo Chemical Co., Ltd. has completed the sale of a portion of its Class A ordinary shares in Rabigh Refining and Petrochemical Company (Petro Rabigh) to Saudi Aramco, reducing its stake from 37.5% to 15%. This transaction makes Saudi Aramco the largest shareholder of Petro Rabigh, holding nearly 60% of the Class A shares. The move is part of a strategic effort to improve Petro Rabigh’s financial structure and support its turnaround plan. Sumitomo Chemical and Saudi Aramco have also subscribed to new Class B ordinary shares issued by Petro Rabigh, which will aid in prepaying debts and reducing accumulated losses. The financial impact on Sumitomo Chemical includes a projected profit of approximately 35 billion yen before tax for the third quarter of the fiscal year ending March 31, 2026, despite recording a loss on valuation of the newly acquired Class B shares.

The most recent analyst rating on (JP:4005) stock is a Hold with a Yen510.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.

Sumitomo Chemical Sells Petro Rabigh Shares to Boost Financial Structure
Sep 1, 2025

Sumitomo Chemical Co., Ltd. has announced the partial sale of its shares in Rabigh Refining and Petrochemical Company (Petro Rabigh) to Saudi Aramco. This move is part of a strategic plan to enhance Petro Rabigh’s financial structure and support its turnaround efforts. The proceeds from the sale will be reinvested into Petro Rabigh, with both Sumitomo Chemical and Saudi Aramco subscribing to a new class of non-voting ordinary shares. This capital restructuring aims to eliminate accumulated losses without affecting Petro Rabigh’s operations or financial results. The shareholding ratio will shift significantly, with Saudi Aramco increasing its stake to 60%, while Sumitomo Chemical’s shareholding will decrease to 15%. The financial impact on Sumitomo Chemical is still under review, with no immediate changes to its financial forecast.

The most recent analyst rating on (JP:4005) stock is a Hold with a Yen428.00 price target. To see the full list of analyst forecasts on Sumitomo Chemical Co stock, see the JP:4005 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 05, 2025